The International Conference of Harmonisation has at last finalized its organizational reforms that are expected to encourage the group's expansion beyond its current membership of regulators from five regions (Canada, the EU, Japan, Switzerland and the US) and three research-based pharmaceutical industry associations (from the EU, Japan and the US)1.
As reported previously in Scrip Regulatory Affairs, the new organization will still be known as ICH. However, this will stand for the International Council for Harmonisation rather than the...